# Freiheitliche Partei Österreichs

<p align="center"><a href="#voting-intentions">Voting Intentions</a> | <a href="#seats">Seats</a></p>

## Voting Intentions

Last result: **16.2%** (General Election of 29 September 2019)

### Confidence Intervals

| Period     | Polling firm/Commissioner(s) | Median | 80% Confidence Interval | 90% Confidence Interval | 95% Confidence Interval | 99% Confidence Interval |
|:----------:|:----------------:|:-----------:|:-----------------------:|:-----------------------:|:-----------------------:|:-----------------------:|
| N/A | [Poll Average](average.html) | 17.5% | 15.8–19.4% | 15.3–19.9% | 14.9–20.4% | 14.1–21.4% |
| [5–8 July 2021](2021-07-08-UniqueResearch.html) | Unique Research <br> profil | 17.0% | 15.4–18.8% | 14.9–19.3% | 14.6–19.8% | 13.8–20.7% |
| [5–8 July 2021](2021-07-08-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 17.0% | 15.5–18.6% | 15.1–19.1% | 14.8–19.5% | 14.1–20.3% |
| [28 June–2 July 2021](2021-07-02-IFDD.html) | IFDD <br> PULS 24 | 18.0% | 16.3–19.8% | 15.9–20.3% | 15.5–20.8% | 14.7–21.7% |
| [28 June–1 July 2021](2021-07-01-UniqueResearch.html) | Unique Research <br> Heute | 17.0% | 15.4–18.8% | 14.9–19.3% | 14.6–19.8% | 13.8–20.7% |
| [28 June–1 July 2021](2021-07-01-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 15.9% | 14.0–18.2% | 13.5–18.8% | 13.0–19.4% | 12.1–20.5% |
| [29–30 June 2021](2021-06-30-Market.html) | Market <br> Der Standard | 17.0% | 15.4–18.7% | 14.9–19.2% | 14.5–19.7% | 13.8–20.6% |
| [22–24 June 2021](2021-06-24-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 16.0% | 14.1–18.3% | 13.5–18.9% | 13.0–19.5% | 12.2–20.6% |
| [21–24 June 2021](2021-06-24-PeterHajek.html) | Peter Hajek | 18.0% | 16.4–19.8% | 15.9–20.4% | 15.5–20.8% | 14.7–21.7% |
| [22–24 June 2021](2021-06-24-OGM.html) | OGM <br> KURIER | 18.0% | 16.3–19.8% | 15.9–20.3% | 15.5–20.8% | 14.7–21.7% |
| [15–17 June 2021](2021-06-17-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 15.0% | N/A | N/A | N/A | N/A |
| [10–15 June 2021](2021-06-15-IFDD.html) | IFDD <br> PULS 24 | 18.1% | 16.4–19.9% | 15.9–20.4% | 15.5–20.9% | 14.8–21.8% |
| [7–10 June 2021](2021-06-10-UniqueResearch.html) | Unique Research <br> profil | 18.0% | 16.4–19.8% | 15.9–20.4% | 15.5–20.8% | 14.7–21.7% |
| [8–10 June 2021](2021-06-10-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 13.9% | N/A | N/A | N/A | N/A |
| [8–10 June 2021](2021-06-10-Market.html) | Market <br> Der Standard | 16.1% | 14.5–17.8% | 14.1–18.3% | 13.7–18.7% | 13.0–19.6% |
| [31 May–2 June 2021](2021-06-02-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 15.0% | 13.1–17.2% | 12.6–17.9% | 12.2–18.4% | 11.3–19.5% |
| [24–30 May 2021](2021-05-30-Market.html) | Market | 20.0% | 18.4–21.7% | 18.0–22.2% | 17.6–22.6% | 16.9–23.4% |
| [25–27 May 2021](2021-05-27-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 16.0% | 14.1–18.3% | 13.5–18.9% | 13.0–19.5% | 12.2–20.6% |
| [18–20 May 2021](2021-05-20-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 17.0% | 15.1–19.3% | 14.5–19.9% | 14.0–20.5% | 13.1–21.6% |
| [14 May 2021](2021-05-14-DemoxResearch.html) | Demox Research | 18.0% | 16.5–19.6% | 16.1–20.1% | 15.7–20.5% | 15.0–21.3% |
| [11–13 May 2021](2021-05-13-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 17.0% | 15.0–19.3% | 14.4–20.0% | 14.0–20.5% | 13.0–21.7% |
| [10–12 May 2021](2021-05-12-UniqueResearch.html) | Unique Research <br> profil | 18.0% | 16.4–19.8% | 15.9–20.4% | 15.5–20.8% | 14.7–21.7% |
| [4–6 May 2021](2021-05-06-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 17.1% | 15.1–19.4% | 14.5–20.0% | 14.0–20.6% | 13.1–21.7% |
| [27–29 April 2021](2021-04-29-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 16.0% | 14.1–18.3% | 13.6–18.9% | 13.1–19.5% | 12.2–20.6% |
| [26–29 April 2021](2021-04-29-PeterHajek.html) | Peter Hajek <br> APA and ATV | 18.0% | 16.4–19.8% | 15.9–20.4% | 15.5–20.8% | 14.7–21.7% |
| [20–22 April 2021](2021-04-22-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 16.0% | 14.1–18.2% | 13.5–18.9% | 13.0–19.4% | 12.2–20.5% |
| [5–8 April 2021](2021-04-08-UniqueResearch.html) | Unique Research <br> profil | 19.0% | 17.3–20.9% | 16.8–21.4% | 16.4–21.9% | 15.7–22.8% |
| [30 March–1 April 2021](2021-04-01-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 18.0% | 16.5–19.6% | 16.1–20.1% | 15.7–20.5% | 15.0–21.3% |
| [30 March–1 April 2021](2021-04-01-OGM.html) | OGM <br> KURIER | 17.0% | 15.4–18.8% | 14.9–19.3% | 14.5–19.7% | 13.8–20.6% |
| [26–30 March 2021](2021-03-30-Market.html) | Market <br> Der Standard | 15.0% | 13.5–16.7% | 13.0–17.2% | 12.7–17.6% | 12.0–18.5% |
| [23–25 March 2021](2021-03-25-UniqueResearch.html) | Unique Research <br> Heute | 18.0% | 16.4–19.8% | 15.9–20.4% | 15.5–20.8% | 14.7–21.7% |
| [23–25 March 2021](2021-03-25-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 17.0% | 15.0–19.3% | 14.4–19.9% | 13.9–20.5% | 13.0–21.7% |
| [15–17 March 2021](2021-03-17-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 16.1% | 14.1–18.3% | 13.6–19.0% | 13.1–19.5% | 12.2–20.7% |
| [8–11 March 2021](2021-03-11-PeterHajek.html) | Peter Hajek <br> APA and ATV | 17.0% | 15.4–18.8% | 14.9–19.3% | 14.6–19.8% | 13.8–20.7% |
| [1–4 March 2021](2021-03-04-UniqueResearch.html) | Unique Research <br> profil | 17.0% | 15.4–18.8% | 14.9–19.3% | 14.6–19.8% | 13.8–20.7% |
| [2–4 March 2021](2021-03-04-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 17.1% | 15.1–19.4% | 14.5–20.0% | 14.0–20.6% | 13.1–21.7% |
| [15–18 February 2021](2021-02-18-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 16.9% | 15.0–19.2% | 14.4–19.9% | 13.9–20.5% | 13.0–21.6% |
| [15–17 February 2021](2021-02-17-Market.html) | Market <br> Der Standard | 14.0% | 12.7–15.5% | 12.3–15.9% | 12.0–16.3% | 11.4–17.0% |
| [8–11 February 2021](2021-02-11-UniqueResearch.html) | Unique Research <br> profil | 17.0% | 15.4–18.8% | 14.9–19.3% | 14.6–19.8% | 13.8–20.7% |
| [8–11 February 2021](2021-02-11-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 16.0% | 14.1–18.3% | 13.5–18.9% | 13.0–19.5% | 12.2–20.6% |
| [1–4 February 2021](2021-02-04-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 15.0% | 13.1–17.2% | 12.6–17.8% | 12.1–18.4% | 11.3–19.5% |
| [25 January–1 February 2021](2021-02-01-IFDD.html) | IFDD <br> Kronen Zeitung | 18.0% | 16.4–19.8% | 15.9–20.4% | 15.5–20.8% | 14.7–21.7% |
| [11–14 January 2021](2021-01-14-UniqueResearch.html) | Unique Research <br> profil | 16.0% | 14.4–17.8% | 14.0–18.3% | 13.6–18.7% | 12.9–19.6% |
| [4–7 January 2021](2021-01-07-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 16.0% | 14.6–17.6% | 14.2–18.0% | 13.9–18.4% | 13.2–19.2% |
| [17–21 December 2020](2020-12-21-Market.html) | Market <br> Der Standard | 13.0% | 11.6–14.6% | 11.2–15.1% | 10.8–15.5% | 10.2–16.3% |
| [15–17 December 2020](2020-12-17-OGM.html) | OGM <br> KURIER | 13.0% | 11.6–14.6% | 11.1–15.1% | 10.8–15.5% | 10.2–16.3% |
| [8–12 December 2020](2020-12-12-PeterHajek.html) | Peter Hajek <br> APA and ATV | 16.0% | 14.4–17.8% | 14.0–18.3% | 13.6–18.7% | 12.9–19.6% |
| [5 December 2020](2020-12-05-UniqueResearch.html) | Unique Research <br> profil | 15.0% | 13.5–16.7% | 13.1–17.2% | 12.7–17.6% | 12.0–18.5% |
| [30 November–3 December 2020](2020-12-03-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 13.0% | 11.2–15.1% | 10.8–15.7% | 10.3–16.2% | 9.6–17.3% |
| [30 November–2 December 2020](2020-12-02-Market.html) | Market <br> Der Standard | 14.0% | 12.5–15.7% | 12.1–16.2% | 11.8–16.6% | 11.1–17.4% |
| [17–19 November 2020](2020-11-19-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 12.0% | 10.3–14.0% | 9.8–14.6% | 9.4–15.1% | 8.7–16.2% |
| [9–12 November 2020](2020-11-12-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 12.0% | 10.8–13.4% | 10.4–13.8% | 10.1–14.2% | 9.6–14.9% |
| [5–7 November 2020](2020-11-07-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 10.6% | 9.0–12.6% | 8.6–13.1% | 8.2–13.6% | 7.5–14.6% |
| [2–6 November 2020](2020-11-06-UniqueResearch.html) | Unique Research | 16.0% | 14.5–17.8% | 14.0–18.3% | 13.7–18.7% | 13.0–19.6% |
| [27–29 October 2020](2020-10-29-ResearchAffairs.html) | Research Affairs | 10.0% | 8.5–11.9% | 8.0–12.5% | 7.7–13.0% | 7.0–13.9% |
| [20–22 October 2020](2020-10-22-ResearchAffairs.html) | Research Affairs | 10.0% | 8.5–11.9% | 8.0–12.5% | 7.7–13.0% | 7.0–13.9% |
| [20–22 October 2020](2020-10-22-OGM.html) | OGM | 11.0% | 10.0–12.0% | 9.8–12.3% | 9.6–12.6% | 9.1–13.1% |
| [12–16 October 2020](2020-10-16-UniqueResearch.html) | Unique Research | 13.0% | 11.6–14.7% | 11.2–15.1% | 10.9–15.5% | 10.2–16.4% |
| [6–8 October 2020](2020-10-08-ResearchAffairs.html) | Research Affairs | 11.0% | 9.4–13.0% | 9.0–13.6% | 8.6–14.1% | 7.9–15.1% |
| [28–30 September 2020](2020-09-30-ResearchAffairs.html) | Research Affairs | 11.0% | 9.4–13.0% | 8.9–13.5% | 8.6–14.1% | 7.8–15.1% |
| [21–24 September 2020](2020-09-24-ResearchAffairs.html) | Research Affairs | 12.1% | 10.4–14.1% | 9.9–14.7% | 9.5–15.2% | 8.7–16.2% |
| [14–18 September 2020](2020-09-18-UniqueResearch.html) | Unique Research | 16.0% | 14.5–17.8% | 14.0–18.3% | 13.7–18.7% | 13.0–19.6% |
| [14–16 September 2020](2020-09-16-ResearchAffairs.html) | Research Affairs | 12.1% | 10.9–13.5% | 10.5–13.9% | 10.2–14.3% | 9.6–15.0% |
| [25–27 August 2020](2020-08-27-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 13.0% | 11.2–15.1% | 10.7–15.7% | 10.3–16.2% | 9.5–17.3% |
| [17–20 August 2020](2020-08-20-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 13.1% | 11.3–15.2% | 10.8–15.8% | 10.4–16.3% | 9.6–17.4% |
| [10–13 August 2020](2020-08-13-UniqueResearch.html) | Unique Research <br> profil | 15.0% | 13.5–16.7% | 13.1–17.2% | 12.7–17.6% | 12.0–18.5% |
| [20–22 July 2020](2020-07-22-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 11.0% | 9.4–13.0% | 8.9–13.5% | 8.6–14.1% | 7.8–15.1% |
| [13–16 July 2020](2020-07-16-UniqueResearch.html) | Unique Research <br> profil | 15.0% | 13.5–16.7% | 13.0–17.2% | 12.7–17.6% | 12.0–18.5% |
| [6–9 July 2020](2020-07-09-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 10.9% | 9.3–12.9% | 8.9–13.5% | 8.5–14.0% | 7.8–15.0% |
| [23–25 June 2020](2020-06-25-OGM.html) | OGM | 13.0% | 11.6–14.7% | 11.2–15.2% | 10.9–15.6% | 10.2–16.4% |
| [9–12 June 2020](2020-06-12-UniqueResearch.html) | Unique Research <br> profil | 14.0% | 12.5–15.7% | 12.1–16.1% | 11.7–16.6% | 11.1–17.4% |
| [5–10 June 2020](2020-06-10-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 12.0% | 10.8–13.4% | 10.4–13.8% | 10.1–14.2% | 9.6–14.9% |
| [5–9 June 2020](2020-06-09-KarmasinResearchIdentity.html) | Karmasin Research & Identity | 13.0% | 11.7–14.5% | 11.4–14.9% | 11.1–15.2% | 10.5–16.0% |
| [25–28 May 2020](2020-05-28-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 12.0% | 10.8–13.4% | 10.4–13.8% | 10.1–14.2% | 9.6–14.9% |
| [21–26 May 2020](2020-05-26-Market.html) | Market <br> Der Standard | 12.0% | 10.6–13.6% | 10.2–14.0% | 9.9–14.4% | 9.3–15.2% |
| [18–19 May 2020](2020-05-19-Market.html) | Market <br> Der Standard | 12.0% | 10.8–13.4% | 10.4–13.8% | 10.1–14.2% | 9.6–14.9% |
| [11–14 May 2020](2020-05-14-UniqueResearch.html) | Unique Research <br> profil | 14.0% | 12.5–15.7% | 12.1–16.1% | 11.7–16.6% | 11.1–17.4% |
| [11–13 May 2020](2020-05-13-Market.html) | Market <br> Der Standard | 11.0% | 9.8–12.4% | 9.5–12.8% | 9.2–13.1% | 8.7–13.8% |
| [20–22 April 2020](2020-04-22-Market.html) | Market | 10.0% | 8.9–11.3% | 8.6–11.7% | 8.3–12.0% | 7.8–12.7% |
| [13–16 April 2020](2020-04-16-UniqueResearch.html) | Unique Research <br> profil | 13.0% | 11.6–14.7% | 11.2–15.1% | 10.9–15.5% | 10.2–16.4% |
| [3–7 April 2020](2020-04-07-Market.html) | Market <br> Der Standard | 11.0% | 10.1–12.0% | 9.8–12.3% | 9.6–12.5% | 9.2–13.0% |
| [31 March–2 April 2020](2020-04-02-OGM.html) | OGM | 12.0% | 10.6–13.6% | 10.2–14.1% | 9.9–14.4% | 9.3–15.2% |
| [24–31 March 2020](2020-03-31-Market.html) | Market <br> Der Standard | 11.0% | 9.8–12.4% | 9.5–12.8% | 9.2–13.1% | 8.7–13.8% |
| [9–13 March 2020](2020-03-13-UniqueResearch.html) | Unique Research | 17.0% | 15.4–18.8% | 15.0–19.3% | 14.6–19.8% | 13.8–20.7% |
| [11–12 March 2020](2020-03-12-Market.html) | Market <br> Der Standard | 13.0% | 11.7–14.5% | 11.4–14.9% | 11.1–15.2% | 10.5–16.0% |
| [5–11 March 2020](2020-03-11-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 12.3% | 11.0–13.7% | 10.7–14.1% | 10.4–14.5% | 9.8–15.2% |
| [24–27 February 2020](2020-02-27-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 11.1% | 9.9–12.4% | 9.6–12.8% | 9.3–13.2% | 8.7–13.9% |
| [10–14 February 2020](2020-02-14-UniqueResearch.html) | Unique Research <br> profil | 16.0% | 14.5–17.8% | 14.0–18.3% | 13.7–18.7% | 13.0–19.6% |
| [7–12 February 2020](2020-02-12-ResearchAffairs.html) | Research Affairs | 13.0% | 11.5–14.8% | 11.0–15.3% | 10.7–15.8% | 10.0–16.7% |
| [4–6 February 2020](2020-02-06-Market.html) | Market | 15.0% | 13.5–16.7% | 13.1–17.2% | 12.7–17.6% | 12.0–18.5% |
| [28–31 January 2020](2020-01-31-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 13.0% | 11.2–15.1% | 10.7–15.7% | 10.3–16.2% | 9.5–17.3% |
| [17–23 January 2020](2020-01-23-ResearchAffairs.html) | Research Affairs | 13.0% | 11.6–14.6% | 11.2–15.0% | 10.9–15.4% | 10.3–16.2% |
| [10–16 January 2020](2020-01-16-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 13.0% | 11.7–14.4% | 11.3–14.8% | 11.0–15.2% | 10.4–15.9% |
| [10–15 January 2020](2020-01-15-KarmasinResearchIdentity.html) | Karmasin Research & Identity | 15.0% | 13.6–16.5% | 13.2–17.0% | 12.9–17.4% | 12.3–18.1% |
| [6–10 January 2020](2020-01-10-UniqueResearch.html) | Unique Research <br> profil | 16.0% | 14.4–17.8% | 14.0–18.3% | 13.6–18.7% | 12.9–19.6% |
| [3–9 January 2020](2020-01-09-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 13.0% | 11.7–14.6% | 11.3–15.1% | 10.9–15.5% | 10.3–16.2% |
| [12–19 December 2019](2019-12-19-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 15.1% | 13.6–16.7% | 13.2–17.2% | 12.8–17.6% | 12.2–18.4% |
| [16–19 December 2019](2019-12-19-Market.html) | Market <br> Der Standard | 14.0% | 12.6–15.7% | 12.1–16.2% | 11.8–16.6% | 11.1–17.4% |
| [9–13 December 2019](2019-12-13-UniqueResearch.html) | Unique Research <br> profil | 15.0% | 13.5–16.7% | 13.1–17.2% | 12.7–17.6% | 12.0–18.5% |
| [6–12 December 2019](2019-12-12-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 14.1% | 12.6–15.7% | 12.2–16.1% | 11.9–16.5% | 11.3–17.3% |
| [29 November–5 December 2019](2019-12-05-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 14.0% | 12.5–15.6% | 12.1–16.1% | 11.8–16.5% | 11.1–17.3% |
| [29 November–4 December 2019](2019-12-04-Market.html) | Market <br> Der Standard | 15.0% | 13.5–16.8% | 13.1–17.3% | 12.7–17.7% | 12.0–18.5% |
| [22–28 November 2019](2019-11-28-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 14.0% | 12.5–15.6% | 12.1–16.0% | 11.8–16.4% | 11.2–17.2% |
| [15–21 November 2019](2019-11-21-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 14.0% | 12.6–15.6% | 12.2–16.1% | 11.9–16.5% | 11.2–17.3% |
| [11–15 November 2019](2019-11-15-UniqueResearch.html) | Unique Research <br> profil | 17.0% | 15.4–18.8% | 15.0–19.3% | 14.6–19.8% | 13.9–20.6% |
| [8–14 November 2019](2019-11-14-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 15.0% | 13.6–16.7% | 13.1–17.2% | 12.8–17.6% | 12.1–18.5% |
| [8–13 November 2019](2019-11-13-KarmasinResearchIdentity.html) | Karmasin Research & Identity | 15.0% | 14.2–15.9% | 14.0–16.1% | 13.8–16.3% | 13.4–16.8% |
| [2–7 November 2019](2019-11-07-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 15.0% | 13.6–16.5% | 13.2–16.9% | 12.9–17.3% | 12.3–18.1% |
| [26–31 October 2019](2019-10-31-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 15.0% | 13.4–16.7% | 13.0–17.2% | 12.7–17.6% | 11.9–18.5% |
| [22–25 October 2019](2019-10-25-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 15.0% | 13.6–16.5% | 13.2–17.0% | 12.9–17.4% | 12.3–18.1% |
| [14–19 October 2019](2019-10-19-Market.html) | Market <br> Der Standard | 16.0% | 14.4–17.7% | 14.0–18.2% | 13.6–18.7% | 12.9–19.5% |
| [15–17 October 2019](2019-10-17-Market.html) | Market <br> Der Standard | 16.0% | 14.4–17.7% | 14.0–18.2% | 13.6–18.7% | 12.9–19.5% |
| [10–16 October 2019](2019-10-16-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 15.0% | 13.6–16.5% | 13.2–17.0% | 12.9–17.3% | 12.3–18.1% |
| [7–11 October 2019](2019-10-11-UniqueResearch.html) | Unique Research <br> profil | 17.0% | 15.4–18.8% | 14.9–19.3% | 14.5–19.7% | 13.8–20.6% |

### Probability Mass Function

The following table shows the probability mass function per percentage block of voting intentions for the [poll average](average.html) for Freiheitliche Partei Österreichs.

| Voting Intentions | Probability | Accumulated | Special Marks |
|:-----------------:|:-----------:|:-----------:|:-------------:|
| 11.5–12.5% | 0% | 100% |  |
| 12.5–13.5% | 0.1% | 100% |  |
| 13.5–14.5% | 1.1% | 99.9% |  |
| 14.5–15.5% | 6% | 98.8% |  |
| 15.5–16.5% | 17% | 93% | Last Result |
| 16.5–17.5% | 26% | 76% |  |
| 17.5–18.5% | 26% | 50% | Median |
| 18.5–19.5% | 16% | 24% |  |
| 19.5–20.5% | 6% | 8% |  |
| 20.5–21.5% | 2% | 2% |  |
| 21.5–22.5% | 0.3% | 0.4% |  |
| 22.5–23.5% | 0% | 0% |  |


## Seats

Last result: **31** seats (General Election of 29 September 2019)

### Confidence Intervals

| Period     | Polling firm/Commissioner(s) | Median | 80% Confidence Interval | 90% Confidence Interval | 95% Confidence Interval | 99% Confidence Interval |
|:----------:|:----------------:|:------:|:-----------------------:|:-----------------------:|:-----------------------:|:-----------------------:|
| N/A | [Poll Average](average.html) | 32 | 29–36 | 28–37 | 28–38 | 26–40 |
| [5–8 July 2021](2021-07-08-UniqueResearch.html) | Unique Research <br> profil | 32 | 29–35 | 28–36 | 27–37 | 26–39 |
| [5–8 July 2021](2021-07-08-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 32 | 29–35 | 28–36 | 27–36 | 26–38 |
| [28 June–2 July 2021](2021-07-02-IFDD.html) | IFDD <br> PULS 24 | 32 | 29–36 | 29–37 | 28–38 | 27–40 |
| [28 June–1 July 2021](2021-07-01-UniqueResearch.html) | Unique Research <br> Heute | 31 | 28–35 | 27–36 | 27–36 | 25–38 |
| [28 June–1 July 2021](2021-07-01-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 29 | 25–33 | 25–34 | 24–36 | 22–38 |
| [29–30 June 2021](2021-06-30-Market.html) | Market <br> Der Standard | 32 | 29–35 | 28–36 | 27–37 | 26–38 |
| [22–24 June 2021](2021-06-24-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 29 | 26–34 | 25–35 | 24–36 | 22–38 |
| [21–24 June 2021](2021-06-24-PeterHajek.html) | Peter Hajek | 34 | 30–37 | 29–38 | 29–39 | 27–40 |
| [22–24 June 2021](2021-06-24-OGM.html) | OGM <br> KURIER | 34 | 30–37 | 29–38 | 29–39 | 27–41 |
| [15–17 June 2021](2021-06-17-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH |  |  |  |  |  |
| [10–15 June 2021](2021-06-15-IFDD.html) | IFDD <br> PULS 24 | 33 | 30–37 | 29–38 | 28–38 | 27–40 |
| [7–10 June 2021](2021-06-10-UniqueResearch.html) | Unique Research <br> profil | 34 | 30–37 | 29–38 | 29–39 | 27–40 |
| [8–10 June 2021](2021-06-10-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH |  |  |  |  |  |
| [8–10 June 2021](2021-06-10-Market.html) | Market <br> Der Standard | 29 | 27–33 | 26–34 | 25–34 | 24–36 |
| [31 May–2 June 2021](2021-06-02-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 29 | 25–32 | 24–33 | 23–34 | 21–36 |
| [24–30 May 2021](2021-05-30-Market.html) | Market | 37 | 34–41 | 34–41 | 33–42 | 32–43 |
| [25–27 May 2021](2021-05-27-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 30 | 26–34 | 25–35 | 24–36 | 22–38 |
| [18–20 May 2021](2021-05-20-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 32 | 28–36 | 27–37 | 26–38 | 24–40 |
| [14 May 2021](2021-05-14-DemoxResearch.html) | Demox Research | 34 | 31–37 | 30–38 | 29–39 | 28–40 |
| [11–13 May 2021](2021-05-13-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 32 | 28–36 | 27–37 | 26–38 | 24–41 |
| [10–12 May 2021](2021-05-12-UniqueResearch.html) | Unique Research <br> profil | 34 | 31–37 | 30–38 | 29–39 | 27–41 |
| [4–6 May 2021](2021-05-06-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 32 | 28–36 | 27–37 | 26–38 | 24–41 |
| [27–29 April 2021](2021-04-29-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 29 | 26–34 | 25–35 | 24–36 | 22–38 |
| [26–29 April 2021](2021-04-29-PeterHajek.html) | Peter Hajek <br> APA and ATV | 34 | 30–37 | 29–38 | 29–39 | 27–40 |
| [20–22 April 2021](2021-04-22-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 30 | 26–34 | 25–35 | 24–36 | 22–38 |
| [5–8 April 2021](2021-04-08-UniqueResearch.html) | Unique Research <br> profil | 35 | 32–39 | 31–40 | 30–41 | 29–42 |
| [30 March–1 April 2021](2021-04-01-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 33 | 30–37 | 30–38 | 29–38 | 28–40 |
| [30 March–1 April 2021](2021-04-01-OGM.html) | OGM <br> KURIER | 32 | 29–35 | 28–36 | 27–37 | 26–39 |
| [26–30 March 2021](2021-03-30-Market.html) | Market <br> Der Standard | 28 | 25–31 | 24–32 | 23–32 | 22–34 |
| [23–25 March 2021](2021-03-25-UniqueResearch.html) | Unique Research <br> Heute | 33 | 30–36 | 29–37 | 28–38 | 27–40 |
| [23–25 March 2021](2021-03-25-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 31 | 27–35 | 26–36 | 25–38 | 24–40 |
| [15–17 March 2021](2021-03-17-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 30 | 26–34 | 25–35 | 24–36 | 22–38 |
| [8–11 March 2021](2021-03-11-PeterHajek.html) | Peter Hajek <br> APA and ATV | 32 | 29–35 | 28–36 | 27–37 | 26–39 |
| [1–4 March 2021](2021-03-04-UniqueResearch.html) | Unique Research <br> profil | 32 | 29–35 | 28–36 | 27–37 | 26–38 |
| [2–4 March 2021](2021-03-04-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 32 | 28–36 | 27–37 | 26–38 | 24–41 |
| [15–18 February 2021](2021-02-18-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 31 | 27–36 | 26–37 | 25–38 | 24–40 |
| [15–17 February 2021](2021-02-17-Market.html) | Market <br> Der Standard | 26 | 23–29 | 23–30 | 22–30 | 21–32 |
| [8–11 February 2021](2021-02-11-UniqueResearch.html) | Unique Research <br> profil | 32 | 29–35 | 28–36 | 27–37 | 26–39 |
| [8–11 February 2021](2021-02-11-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 30 | 26–34 | 25–35 | 24–36 | 22–39 |
| [1–4 February 2021](2021-02-04-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 28 | 24–32 | 23–33 | 22–34 | 21–36 |
| [25 January–1 February 2021](2021-02-01-IFDD.html) | IFDD <br> Kronen Zeitung | 34 | 30–37 | 29–38 | 29–39 | 27–40 |
| [11–14 January 2021](2021-01-14-UniqueResearch.html) | Unique Research <br> profil | 29 | 26–33 | 26–34 | 25–34 | 24–36 |
| [4–7 January 2021](2021-01-07-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 30 | 27–33 | 26–34 | 25–34 | 24–36 |
| [17–21 December 2020](2020-12-21-Market.html) | Market <br> Der Standard | 24 | 21–27 | 21–28 | 20–29 | 19–30 |
| [15–17 December 2020](2020-12-17-OGM.html) | OGM <br> KURIER | 24 | 21–27 | 21–28 | 20–29 | 19–30 |
| [8–12 December 2020](2020-12-12-PeterHajek.html) | Peter Hajek <br> APA and ATV | 29 | 26–33 | 26–34 | 25–34 | 24–36 |
| [5 December 2020](2020-12-05-UniqueResearch.html) | Unique Research <br> profil | 28 | 25–31 | 24–32 | 23–33 | 22–34 |
| [30 November–3 December 2020](2020-12-03-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 25 | 21–28 | 20–30 | 19–31 | 18–33 |
| [30 November–2 December 2020](2020-12-02-Market.html) | Market <br> Der Standard | 26 | 23–29 | 22–30 | 22–31 | 20–32 |
| [17–19 November 2020](2020-11-19-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 23 | 19–26 | 18–28 | 18–29 | 16–31 |
| [9–12 November 2020](2020-11-12-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 23 | 20–25 | 20–26 | 19–27 | 18–28 |
| [5–7 November 2020](2020-11-07-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 20 | 17–23 | 16–25 | 15–25 | 14–27 |
| [2–6 November 2020](2020-11-06-UniqueResearch.html) | Unique Research | 30 | 27–33 | 26–34 | 25–35 | 24–37 |
| [27–29 October 2020](2020-10-29-ResearchAffairs.html) | Research Affairs | 19 | 16–22 | 15–24 | 14–24 | 13–26 |
| [20–22 October 2020](2020-10-22-ResearchAffairs.html) | Research Affairs | 19 | 16–22 | 15–23 | 14–24 | 13–26 |
| [20–22 October 2020](2020-10-22-OGM.html) | OGM | 20 | 18–22 | 18–23 | 18–23 | 17–24 |
| [12–16 October 2020](2020-10-16-UniqueResearch.html) | Unique Research | 24 | 22–27 | 21–28 | 20–29 | 19–31 |
| [6–8 October 2020](2020-10-08-ResearchAffairs.html) | Research Affairs | 20 | 17–24 | 16–25 | 16–26 | 14–28 |
| [28–30 September 2020](2020-09-30-ResearchAffairs.html) | Research Affairs | 20 | 17–24 | 16–25 | 16–26 | 14–28 |
| [21–24 September 2020](2020-09-24-ResearchAffairs.html) | Research Affairs | 23 | 19–27 | 18–28 | 18–29 | 16–31 |
| [14–18 September 2020](2020-09-18-UniqueResearch.html) | Unique Research | 30 | 27–33 | 26–34 | 25–34 | 24–36 |
| [14–16 September 2020](2020-09-16-ResearchAffairs.html) | Research Affairs | 22 | 20–25 | 19–25 | 18–26 | 18–27 |
| [25–27 August 2020](2020-08-27-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 24 | 21–28 | 20–29 | 19–30 | 18–32 |
| [17–20 August 2020](2020-08-20-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 24 | 21–28 | 20–29 | 19–30 | 18–32 |
| [10–13 August 2020](2020-08-13-UniqueResearch.html) | Unique Research <br> profil | 28 | 25–31 | 24–32 | 23–32 | 22–34 |
| [20–22 July 2020](2020-07-22-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 21 | 17–24 | 16–25 | 16–26 | 14–28 |
| [13–16 July 2020](2020-07-16-UniqueResearch.html) | Unique Research <br> profil | 28 | 25–31 | 24–32 | 23–32 | 22–34 |
| [6–9 July 2020](2020-07-09-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 21 | 17–24 | 16–25 | 16–26 | 14–29 |
| [23–25 June 2020](2020-06-25-OGM.html) | OGM | 24 | 21–27 | 21–28 | 20–29 | 19–30 |
| [9–12 June 2020](2020-06-12-UniqueResearch.html) | Unique Research <br> profil | 26 | 23–29 | 22–30 | 21–30 | 20–32 |
| [5–10 June 2020](2020-06-10-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 23 | 20–25 | 20–26 | 19–27 | 18–28 |
| [5–9 June 2020](2020-06-09-KarmasinResearchIdentity.html) | Karmasin Research & Identity | 24 | 22–27 | 21–28 | 21–28 | 19–30 |
| [25–28 May 2020](2020-05-28-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 23 | 20–25 | 19–26 | 19–27 | 18–28 |
| [21–26 May 2020](2020-05-26-Market.html) | Market <br> Der Standard | 22 | 19–25 | 19–26 | 18–26 | 17–28 |
| [18–19 May 2020](2020-05-19-Market.html) | Market <br> Der Standard | 22 | 20–25 | 19–25 | 18–26 | 17–27 |
| [11–14 May 2020](2020-05-14-UniqueResearch.html) | Unique Research <br> profil | 26 | 23–29 | 22–30 | 22–31 | 20–32 |
| [11–13 May 2020](2020-05-13-Market.html) | Market <br> Der Standard | 20 | 18–23 | 17–23 | 17–24 | 16–25 |
| [20–22 April 2020](2020-04-22-Market.html) | Market | 18 | 16–21 | 16–21 | 15–22 | 14–23 |
| [13–16 April 2020](2020-04-16-UniqueResearch.html) | Unique Research <br> profil | 24 | 21–27 | 20–28 | 20–28 | 19–30 |
| [3–7 April 2020](2020-04-07-Market.html) | Market <br> Der Standard | 20 | 18–22 | 18–22 | 18–23 | 17–24 |
| [31 March–2 April 2020](2020-04-02-OGM.html) | OGM | 22 | 20–25 | 19–26 | 18–27 | 17–28 |
| [24–31 March 2020](2020-03-31-Market.html) | Market <br> Der Standard | 20 | 18–23 | 17–23 | 17–24 | 16–25 |
| [9–13 March 2020](2020-03-13-UniqueResearch.html) | Unique Research | 32 | 29–35 | 28–36 | 27–37 | 26–39 |
| [11–12 March 2020](2020-03-12-Market.html) | Market <br> Der Standard | 24 | 21–26 | 21–27 | 20–28 | 19–29 |
| [5–11 March 2020](2020-03-11-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 23 | 20–25 | 20–26 | 19–27 | 18–28 |
| [24–27 February 2020](2020-02-27-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 20 | 18–23 | 17–23 | 17–24 | 16–25 |
| [10–14 February 2020](2020-02-14-UniqueResearch.html) | Unique Research <br> profil | 30 | 27–33 | 26–34 | 25–35 | 24–37 |
| [7–12 February 2020](2020-02-12-ResearchAffairs.html) | Research Affairs | 24 | 21–27 | 20–28 | 19–29 | 18–31 |
| [4–6 February 2020](2020-02-06-Market.html) | Market | 28 | 25–31 | 24–32 | 23–32 | 22–34 |
| [28–31 January 2020](2020-01-31-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 24 | 20–28 | 20–29 | 19–30 | 17–32 |
| [17–23 January 2020](2020-01-23-ResearchAffairs.html) | Research Affairs | 24 | 21–27 | 21–28 | 20–29 | 19–30 |
| [10–16 January 2020](2020-01-16-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 24 | 21–26 | 21–27 | 20–28 | 19–29 |
| [10–15 January 2020](2020-01-15-KarmasinResearchIdentity.html) | Karmasin Research & Identity | 28 | 25–31 | 25–32 | 24–33 | 23–34 |
| [6–10 January 2020](2020-01-10-UniqueResearch.html) | Unique Research <br> profil | 30 | 27–33 | 26–34 | 25–35 | 24–37 |
| [3–9 January 2020](2020-01-09-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 24 | 21–27 | 20–27 | 20–28 | 19–30 |
| [12–19 December 2019](2019-12-19-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 28 | 25–31 | 24–32 | 24–33 | 22–34 |
| [16–19 December 2019](2019-12-19-Market.html) | Market <br> Der Standard | 26 | 23–29 | 22–30 | 22–31 | 20–32 |
| [9–13 December 2019](2019-12-13-UniqueResearch.html) | Unique Research <br> profil | 28 | 25–31 | 24–32 | 23–32 | 22–34 |
| [6–12 December 2019](2019-12-12-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 26 | 23–29 | 22–29 | 22–30 | 20–32 |
| [29 November–5 December 2019](2019-12-05-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 26 | 23–29 | 22–30 | 21–31 | 20–32 |
| [29 November–4 December 2019](2019-12-04-Market.html) | Market <br> Der Standard | 28 | 25–31 | 24–32 | 23–33 | 22–34 |
| [22–28 November 2019](2019-11-28-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 26 | 23–29 | 22–30 | 22–31 | 20–32 |
| [15–21 November 2019](2019-11-21-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 26 | 23–29 | 23–30 | 22–31 | 21–32 |
| [11–15 November 2019](2019-11-15-UniqueResearch.html) | Unique Research <br> profil | 31 | 28–35 | 28–36 | 27–36 | 25–38 |
| [8–14 November 2019](2019-11-14-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 28 | 25–31 | 25–32 | 24–33 | 22–35 |
| [8–13 November 2019](2019-11-13-KarmasinResearchIdentity.html) | Karmasin Research & Identity | 28 | 27–30 | 26–30 | 26–31 | 25–31 |
| [2–7 November 2019](2019-11-07-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 28 | 25–31 | 25–32 | 24–32 | 23–34 |
| [26–31 October 2019](2019-10-31-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 28 | 25–31 | 24–32 | 24–33 | 22–35 |
| [22–25 October 2019](2019-10-25-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 28 | 25–31 | 24–32 | 24–32 | 22–34 |
| [14–19 October 2019](2019-10-19-Market.html) | Market <br> Der Standard | 30 | 27–33 | 26–34 | 25–35 | 24–36 |
| [15–17 October 2019](2019-10-17-Market.html) | Market <br> Der Standard | 30 | 27–33 | 26–34 | 25–35 | 24–36 |
| [10–16 October 2019](2019-10-16-ResearchAffairs.html) | Research Affairs <br> ÖSTERREICH | 27 | 25–31 | 25–31 | 23–32 | 22–34 |
| [7–11 October 2019](2019-10-11-UniqueResearch.html) | Unique Research <br> profil | 32 | 28–35 | 28–36 | 27–37 | 26–38 |

### Probability Mass Function

![Graph with seats probability mass function not yet produced](average-seats-pmf-freiheitlicheparteiösterreichs.png "Seats Probability Mass Function")

The following table shows the probability mass function per seat for the [poll average](average.html) for Freiheitliche Partei Österreichs.

| Number of Seats | Probability | Accumulated | Special Marks |
|:---------------:|:-----------:|:-----------:|:-------------:|
| 25 | 0.2% | 100% |  |
| 26 | 0.6% | 99.8% |  |
| 27 | 2% | 99.2% |  |
| 28 | 3% | 98% |  |
| 29 | 7% | 94% |  |
| 30 | 10% | 88% |  |
| 31 | 14% | 78% | Last Result |
| 32 | 16% | 64% | Median |
| 33 | 14% | 48% |  |
| 34 | 12% | 34% |  |
| 35 | 9% | 22% |  |
| 36 | 6% | 13% |  |
| 37 | 4% | 7% |  |
| 38 | 2% | 3% |  |
| 39 | 0.9% | 2% |  |
| 40 | 0.4% | 0.6% |  |
| 41 | 0.1% | 0.2% |  |
| 42 | 0.1% | 0.1% |  |
| 43 | 0% | 0% |  |


